Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-020-04257-2.pdf
Reference32 articles.
1. Frederiksen H, Christiansen CF, Norgaard M (2012) Risk and prognosis of adult primary immune thrombocytopenia. Expert Rev Hematol 5:219–228. https://doi.org/10.1586/ehm.12.7
2. Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Morel N, Costedoat-Chalumeau N, Pan-Petesch B, Khellaf M, Perlat A, Sacre K, Lefrere F, Abenhaim L, Godeau B, Group for the PGRx-ITP Study (2016) Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome. Haematologica 101:1039–1045. https://doi.org/10.3324/haematol.2016.146373
3. Heitink-Pollé KMJ, Nijsten J, Boonacker CWB, De Haas M, Bruin MCA (2014) Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood 124:3295–3307. https://doi.org/10.1182/blood-2014-04-570127
4. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386–2393. https://doi.org/10.1182/blood-2008-07-162503
5. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3:3780–3817. https://doi.org/10.1182/bloodadvances.2019000812
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health-related quality of life and complications of corticosteroid treatment in patients with immune thrombocytopenia in two teaching hospitals in Ethiopia: A cross-sectional study;2024-02-02
2. Assessing uptake of the core outcome set in clinical trials for immune thrombocytopenia: A cross-sectional analysis;Thrombosis Research;2024-02
3. Experience of 2<sup>nd</sup> line therapy with eltrombopag in patients with immune thrombocytopenia;Oncohematology;2023-09-12
4. Prognosis and risk factors of chronicity in childhood idiopathic thrombocytopenic purpura: a single-center experience;Interdisciplinary Medical Journal;2023-04-30
5. Identification factors to adjust early combination regimens in adult primary immune thrombocytopenia: An 8-year data analysis;Frontiers in Hematology;2023-03-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3